Novartis AG / NeuTec Pharma plc
OFT closed case: Anticipated acquisition by Novartis AG of NeuTec Pharma plc
Affected market: Biopharmaceuticals
On the basis of the information available to it, the Office of Fair Trading has decided that the anticipated acquisition by Novartis AG of NeuTec Pharma plc does not qualify for investigation under the mergers provisions of the Enterprise Act 2002 (the Act), because neither the UK turnover test nor the share of supply test in section 23 of the Act is met. A relevant merger situation has, therefore, not been created.